Science Hub

Welcome to Novo Nordisk Science Hub

The information on this website is intended for healthcare professionals only and is provided for the purpose of scientific exchange.

The website is not country specific and may therefore contain information that is not applicable in your country, thus you may find information concerning study drugs or therapeutic uses that have not been approved by drug regulatory agencies. This website is not intended to promote in any way, any use, either approved, or unapproved, of a Novo Nordisk product or of any other product or serve as basis for any treatment decision or action. Please always refer to Summary of Product Characteristics (product label) as approved by regulatory authorities in your country or contact Novo Nordisk for further information.

Furthermore, the site is not intended to replace the advice of a healthcare professional and should not be construed as providing advice or making a recommendation. Only a physician can determine whether a specific product is correct for a particular patient. Novo Nordisk accepts no liability for the accuracy, completeness or use of this information, and disclaims any liability to update the information contained on this site.

By accessing this website you accept this legal notice and expressly confirm your status as a healthcare professional.

ILC 2021 June 23 -26

Combination treatments including​ semaglutide, cilofexor, and/or firsocostat​ lead to greater improvements in the​ FibroScan-aspartate aminotransferase​ (FAST) score compared to semaglutide​ alone in patients with nonalcoholic​ steatohepatitis​

Alkhouri N1; Herring R2; Kayali Z3; Hassanein T4; Kohli A1; Damgaard LH5; Buchholtz K5; Kjær MS5; Balendran C5; Zhu Y6; Billin A6; Huss RS6; Myers RP6; Loomba R7; Noureddin M8;
1 Arizona Liver Health, Chandler, AZ, USA, Chandler, United States; 2 Quality Medical Research, Nashville, TN, USA, Nashville, United States; 3 Jubilee Clinical Research, Las Vegas, NV, USA, Las Vegas, United States; 4 Southern California Research Center, Coronado, CA, USA, Coronado, United States; 5 Novo Nordisk A/S, Bagsværd, Denmark, Bagsværd, Denmark; 6 Gilead Sciences, Inc., Foster City, CA, USA, Foster City, United States; 7 University of California at San Diego, La Jolla, CA, USA, La Jolla, United States; 8 Cedars-Sinai Medical Center, Los Angeles, CA, USA, Los Angeles, United States;